Abstract
BackgroundPatient and public involvement and co‐production are widely used, but nevertheless contested concepts in applied health research. There is much confusion about what they are, how they might be undertaken and how they relate to each other. There are distinct challenges and particular gaps in public involvement in alcohol research, especially when the study focus is on health matters other than alcohol dependence.ObjectiveTo explore how patient and public involvement and co‐production have been interpreted and applied within a multi‐disciplinary research programme in the development of a complex intervention on alcohol and medicine use in community pharmacies.DesignThe paper presents the authors' critical reflection on a grounded example of how public involvement concepts have been translated into practice in the intervention development phase of a publicly funded research programme, noting its impact on the programme to date.DiscussionCo‐production adds another layer of complexity in the development of a complex intervention. The research planning requirements for publicly funded research circumscribe the possibilities for co‐production, including impacting on the possibility of stability and continuity over time.
Highlights
This paper is co-authored by researchers and two patient and public involvement (PPI) group members from the National Institute for Health Research (NIHR)-funded Community pharmacy: Highlighting Alcohol use in Medication aPpointments-1 (CHAMP-1)
Through critical reflection on a grounded example, the intervention development phase of this programme of applied health research, the paper identifies some of the challenges and benefits of operationalizing co-production and PPI in developing a complex intervention which features the sensitive topic of alcohol consumption
The NIHR in England and the Netherlands Organisation for Health Research and Development (ZonMW) were identified as having, ‘the most extensive involvement of members of the public’ in a survey conducted by authors concerned about avoidable waste in the production and reporting of research evidence.[1]
Summary
This paper is co-authored by researchers and two patient and public involvement (PPI) group members from the National Institute for Health Research (NIHR)-funded Community pharmacy: Highlighting Alcohol use in Medication aPpointments-1 (CHAMP-1). The aim of NIHR Programme Grants for Applied Research (PGfAR) is to deliver research findings that will lead to clear and identifiable patient benefits. Through critical reflection on a grounded example, the intervention development phase of this programme of applied health research, the paper identifies some of the challenges and benefits of operationalizing co-production and PPI in developing a complex intervention which features the sensitive topic of alcohol consumption. While acknowledging the considerable challenges, the authors make a case for the importance of including patients and the public in the production of alcohol, and complex interventions research
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
